A randomized comparison of once- versus twice-daily Mmx® mesalamine for the maintenance of remission in mild-to-moderate ulcerative colitis

被引：0
|
作者：
Kamm, Michael A.
Colombel, Jean-frederic
Kornbluth, Asher
Diebold, Ron
Barrett, Karen
Karlstadt, Robyn G.
Joseph, Raymond E.
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A510 / A510
页数：1
相关论文
共 50 条
  • [21] Time to initial symptom resolution with MMX™ mesalamine therapy for active, mild-to-moderate ulcerative colitis
    Sandborn, William J.
    Karlstadt, Robyn
    Barrett, Karen
    Joseph, Raymond E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S462 - S463
  • [22] ONCE- VERSUS TWICE-DAILY TACROLIMUS AND GRAFT SURVIVAL
    Unterrainer, Christian
    Suesal, Caner
    TRANSPLANTATION, 2020, 104 (09) : S608 - S608
  • [23] Mmx® mesalamine as the sole medication for the induction and maintenance of remission of mild-to-moderate ulcerative colitis:: Outcome in patients treated over 14-16 months
    Kamm, Michael A.
    Hanauer, Stephen B.
    Lichtenstein, Gary R.
    Diebold, Ron
    Barrett, Karen
    Karlstadt, Robyn G.
    Joseph, Raymond E.
    GASTROENTEROLOGY, 2007, 132 (04) : A510 - A510
  • [24] Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis
    Sandborn, William J.
    Korzenik, Joshua
    Lashner, Bret
    Leighton, Jonathan A.
    Mahadevan, Uma
    Marion, James F.
    Safdi, Michael
    Sninsky, Charles A.
    Patel, Raman M.
    Friedenberg, Keith A.
    Dunnmon, Preston
    Ramsey, David
    Kane, Sunanda
    GASTROENTEROLOGY, 2010, 138 (04) : 1286 - U117
  • [25] A systems comparison of once- versus twice-daily milking of pastured dairy cows
    Clark, DA
    Phyn, CVC
    Tong, MJ
    Collis, SJ
    Dalley, DE
    JOURNAL OF DAIRY SCIENCE, 2006, 89 (05) : 1854 - 1862
  • [26] Twice-Daily Dosing of Balsalazide Tablets 3.3 G Is Safe and Effective in the Treatment of Mild-to-Moderate Ulcerative Colitis
    Scherl, Ellen J.
    Pruitt, Ron E.
    Gordon, Glenn L.
    Lamet, Mark
    Shaw, Audrey L.
    Huang, Shirley
    Mareya, Shadreck M.
    Forbes, William P.
    GASTROENTEROLOGY, 2009, 136 (05) : A520 - A520
  • [27] Evaluating induction and maintenance treatment with MMX mesalazine for patients with mild-to-moderate ulcerative colitis
    Solomon, D.
    Abhyankar, B.
    Barrett, K.
    Karlstadt, R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A90 - A90
  • [28] MMX mesalamine, a novel formulation of 5-ASA, effectively induces the remission of active mild-to-moderate ulcerative colitis in men and women
    Lichtenstein, Gary R.
    Sandborn, William J.
    Kamm, Michael A.
    Barrett, Karen
    Joseph, Raymond E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S432 - S432
  • [29] Combined data from two pivotal, randomized, placebo-controlled, phase III studies show that SPD476, a novel mesalamine formulation given once or twice-daily, is effective for the induction of remission of mild-to-moderate ulcerative colitis
    Sandborn, William J.
    Kamm, Michael A.
    Lichtenstein, Gary R.
    Gassull, Miguel
    Schreiber, Stefan
    Jackowski, Lechoslaw
    Boddu, Prabhakar
    Gubergrits, Natalya
    GASTROENTEROLOGY, 2006, 130 (04) : A119 - A119
  • [30] Treatment acceptability in a randomised controlled trial of once-daily or twice-daily mesalazine (Pentasa) for the maintenance of remission in ulcerative colitis
    Dignass, Axel U.
    Bokemeyer, Bernd
    Adamek, H. E.
    Mross, Michael R.
    Vinter-Jensen, Lars
    Boerner, N.
    Silvennoinen, Jouni
    Tan, T. G.
    Oudkerk-Pool, M.
    Stijnen, Theo
    Dietel, Peter
    Klugmann, Tobias
    Veerman, Henri
    GASTROENTEROLOGY, 2008, 134 (04) : A495 - A496
12345